GLP-1 Medication Articles
Ozempic, Wegovy, Mounjaro, Zepbound and how they differ.
What Happens When You Stop GLP-1 Medications?
Research shows most people regain weight after stopping GLP-1 drugs. Here's what the data says, why it happens, and how to plan ahead with your provider.
Wegovy Pill vs Injection: How They Compare in 2026
Novo Nordisk launched the first oral GLP-1 for weight loss in 2026. How the Wegovy pill compares to injections on cost, results, and convenience.
Saxenda vs Ozempic: Which Is Better for Weight Loss?
Saxenda (liraglutide) vs Ozempic (semaglutide) for weight loss: dosing, effectiveness, side effects, cost, and which one might fit you best.
Switching from Ozempic to Mounjaro: What to Expect
Considering a switch from semaglutide to tirzepatide? Here's how the transition works, dose equivalencies, and what patients typically experience.
Compounded Semaglutide vs Brand-Name Wegovy in 2026
Cheap compounded semaglutide is mostly gone as of mid-2026. Here's the accurate picture, plus real ways to make brand-name Wegovy affordable.
GLP-1 for Type 2 Diabetes vs Weight Loss: Key Differences
GLP-1 drugs treat both type 2 diabetes and obesity, but dosing, insurance coverage, and FDA approvals differ significantly between the two uses.
How Semaglutide and Tirzepatide Work for Weight Loss
A science-based explanation of how GLP-1 receptor agonists cause weight loss. How semaglutide and tirzepatide work and why they are effective.
Zepbound vs Mounjaro: Understanding Tirzepatide Options
Zepbound and Mounjaro both contain tirzepatide but are approved for different conditions. Compare their dosing, cost, and insurance coverage.
Ozempic vs Wegovy: What's the Difference?
Both contain semaglutide, but they're FDA-approved for different purposes. Here's what you need to know before choosing between them.